Adgero: Adgero Biopharmaceuticals Holdings Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12042018 Prices from USD $250

SummaryAdgero Biopharmaceuticals Holdings Inc Adgero is a biopharmaceutical company which advances its proprietary late stage photodynamic therapy PDT for the treatment of unmet clinical needs of patients with cutaneous metastatic breast cancer CMBC and bi...